A5068635622- Acute Lymphoblastic Leukemia research
- Pancreatitis Pathology and Treatment
- Obesity and Health Practices
- Global Public Health Policies and Epidemiology
- Lung Cancer Research Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Chronic Kidney Disease and Diabetes
- COVID-19 Clinical Research Studies
- Childhood Cancer Survivors' Quality of Life
- Blood Pressure and Hypertension Studies
- COVID-19 and healthcare impacts
- Chronic Disease Management Strategies
- Health disparities and outcomes
- Healthcare Systems and Reforms
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
2023
Universidad Nacional Autónoma de México
2022
Patients with obesity have an increased risk for adverse COVID-19 outcomes. Body mass index (BMI) does not acknowledge the health burden associated this disease. The performance of Edmonton Obesity Staging System (EOSS), a clinical classification tool that assesses obesity-related comorbidity, is compared BMI, respect to
Abstract Diabetes mellitus (DM) is currently one of the leading causes mortality worldwide. However, disease evolves differently across countries. This study intends to characterize trends and assess potential effects marginalization on DM between 1990 2019 in Mexico. We analyzed death certificates that listed as underlying cause (N = 1,907,173), well extent which changes were associated with through an age-period-cohort analysis. increased Mexico 2019; change was faster first half slowed...
Abstract Globally, diabetes mellitus (DM) is one of the leading causes mortality. However, this behavior may differ over time for countries given their intrinsic factors. The objective study to characterize trend and assess potential effect marginalization on DM mortality during 1990-2019 in Mexico. We analyzed death certificates where was listed as underlying cause (N=1,907,173) extent which changes, were associated with from an age-period-cohort analysis. has increased Mexico period,...
Background: The usefulness of eGFR for screening chronic kidney disease (CKD) in early stages among people with type 2 diabetes (T2D) and hypertension is still under investigation has not been definitively established.